Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1–34) in a rat spinal arthrodesis model

Alkhiary, 2005, Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1–34), J Bone Joint Surg Am, 87, 731, 10.2106/JBJS.D.02115 Andreassen, 1999, Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures, J Bone Miner Res, 14, 960, 10.1359/jbmr.1999.14.6.960 Andreassen, 2004, Treatment with parathyroid hormone hPTH(1–34), hPTH(1–31), and monocyclic hPTH(1–31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase, Calcif Tissue Int, 74, 351, 10.1007/s00223-003-0093-6 Black, 2005, One year of alendronate after one year of parathyroid hormone (1–84) for osteoporosis, N Engl J Med, 353, 555, 10.1056/NEJMoa050336 Boden, 2002, Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute, Spine, 27, S26, 10.1097/00007632-200208151-00007 Boden, 1995, An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics, Spine, 20, 412, 10.1097/00007632-199502001-00003 Boden, 1998, Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1), Spine, 23, 2486, 10.1097/00007632-199812010-00003 Bridwell, 1993, The role of fusion and instrumentation in the treatment of degenerative spondylolisthesis with spinal stenosis, J Spinal Disord, 6, 461, 10.1097/00002517-199306060-00001 Buxton, 2004, Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1–34), J Clin Endocrinol Metab, 89, 3332, 10.1210/jc.2003-032066 Cosman, 2001, Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal, J Bone Miner Res, 16, 925, 10.1359/jbmr.2001.16.5.925 Cypher, 1996, Biological principles of bone graft healing, J Foot Ankle Surg, 35, 413, 10.1016/S1067-2516(96)80061-5 Dempster, 2001, Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study, J Bone Miner Res, 16, 1846, 10.1359/jbmr.2001.16.10.1846 Dempster, 1993, Anabolic actions of parathyroid hormone on bone, Endocr Rev, 14, 690 DeWald, 2006, Instrumentation-related complications of multilevel fusions for adult spinal deformity patients over age 65: surgical considerations and treatment options in patients with poor bone quality, Spine, 31, S144, 10.1097/01.brs.0000236893.65878.39 Ferrari, 2005, Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2, Endocrinology, 146, 1854, 10.1210/en.2004-1282 Finkelstein, 1994, Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency, N Engl J Med, 331, 1618, 10.1056/NEJM199412153312404 Hing, 2004, Bone repair in the twenty-first century: biology, chemistry or engineering?, Philos Transact A Math Phys Eng Sci, 362, 2821, 10.1098/rsta.2004.1466 Hock, 1992, Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone, J Bone Miner Res, 7, 65, 10.1002/jbmr.5650070110 Holzer, 1999, Parathyroid hormone enhances fracture healing. A preliminary report, Clin Orthop Relat Res, 258, 10.1097/00003086-199909000-00033 Horwitz, 2003, Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis, J Clin Endocrinol Metab, 88, 569, 10.1210/jc.2002-021122 Huang, 2005, Alendronate inhibits spine fusion in a rat model, Spine, 30, 2516, 10.1097/01.brs.0000186470.28070.7b Ito, 2002, Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters, Bone, 31, 351, 10.1016/S8756-3282(02)00830-X Kinney, 1998, The relationship between three-dimensional connectivity and the elastic properties of trabecular bone, J Bone Miner Res, 13, 839, 10.1359/jbmr.1998.13.5.839 Komatsubara, 2005, Human parathyroid hormone (1–34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora, Bone, 36, 678, 10.1016/j.bone.2005.02.002 Kon, 2001, Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing, J Bone Miner Res, 16, 1004, 10.1359/jbmr.2001.16.6.1004 Lindsay, 1997, Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis, Lancet, 350, 550, 10.1016/S0140-6736(97)02342-8 Locklin, 2003, Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone, J Cell Biochem, 89, 180, 10.1002/jcb.10490 Ma, 2001, Catabolic effects of continuous human PTH (1–38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation, Endocrinology, 142, 4047, 10.1210/en.142.9.4047 McGuire, 1993, The use of primary internal fixation in spondylolisthesis, Spine, 18, 1662, 10.1097/00007632-199309000-00015 Miyakoshi, 2001, Evidence that anabolic effects of PTH on bone require IGF-I in growing mice, Endocrinology, 142, 4349, 10.1210/en.142.10.4349 Mofidi, 2005, Is high level of disability an indication for spinal fusion? Analysis of long-term outcome after posterior lumbar interbody fusion using carbon fiber cages, J Spinal Disord Tech, 18, 479, 10.1097/01.bsd.0000145481.92783.e7 Nakajima, 2002, Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34), J Bone Miner Res, 17, 2038, 10.1359/jbmr.2002.17.11.2038 Neer, 2001, Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis, N Engl J Med, 344, 1434, 10.1056/NEJM200105103441904 Ondra, 2003, Revision strategies for lumbar pseudarthrosis, Neurosurg Focus, 15, E9, 10.3171/foc.2003.15.3.9 Qin, 2004, Parathyroid hormone: a double-edged sword for bone metabolism, Trends Endocrinol Metab, 15, 60, 10.1016/j.tem.2004.01.006 Salamon, 2003, The effects of BMP-7 in a rat posterolateral intertransverse process fusion model, J Spinal Disord Tech, 16, 90, 10.1097/00024720-200302000-00014 Schimandle, 1994, Spine update. The use of animal models to study spinal fusion, Spine, 19, 1998, 10.1097/00007632-199409000-00023 Seebach, 2004, Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats, J Orthop Res, 22, 472, 10.1016/j.orthres.2003.08.018 Skripitz, 2000, Strong effect of PTH (1–34) on regenerating bone: a time sequence study in rats, Acta Orthop Scand, 71, 619, 10.1080/000164700317362271 Ulrich, 1999, The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone, Bone, 25, 5, 10.1016/S8756-3282(99)00098-8 Vaccaro, 2002, Bone grafting alternatives in spinal surgery, Spine J, 2, 206, 10.1016/S1529-9430(02)00180-8 Vahle, 2002, Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1–34) for 2 years and relevance to human safety, Toxicol Pathol, 30, 312, 10.1080/01926230252929882 West, 1991, Results of spinal arthrodesis with pedicle screw-plate fixation, J Bone Joint Surg Am, 73, 1179, 10.2106/00004623-199173080-00006 Whitecloud, 1994, Operative treatment of the degenerated segment adjacent to a lumbar fusion, Spine, 19, 531, 10.1097/00007632-199403000-00007 Yamaguchi, 2005, Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice, Endocrinology, 146, 2620, 10.1210/en.2004-1511 Zdeblick, 1993, A prospective, randomized study of lumbar fusion. Preliminary results, Spine, 18, 983, 10.1097/00007632-199306150-00006 Zipfel, 2003, Bone grafting, Neurosurg Focus, 14, e8, 10.3171/foc.2003.14.2.9